|
FY2023
12 months to Dec 31, 2023
|
|
|---|---|
| Cash Flows from Operating Activities: | |
| Net Income (loss) | |
| Adjustments to reconcile net loss to net cash (used in)/provided by operating activities: | |
| Interest earned on investments held in Trust Account | |
| Changes in operating assets and liabilities: | |
| Prepaid expenses | |
| Amount due to related parties | |
| Accrued expenses | |
| Net cash (used in)/provided by operating activities | |
| Cash Flows from Investment Activities: | |
| Purchase of investments held in Trust Account | |
| Net cash used in investing activities | |
| Cash Flows from Financing Activities: | |
| Proceeds from sale of public units through public offering | |
| Proceeds from sale of private placement units | |
| Payment of underwriter's discount and commissions | |
| Payments of deferred offering costs | |
| Net cash provided by financing activities | |
| Net change in cash | |
| Cash, beginning of the year | |
| Cash, end of the year | |
| Supplemental disclosure of non-cash activities: | |
| Deferred underwriting discounts and commissions | |
| Offering costs charged against additional paid-in capital | |
| Remeasurement for ordinary shares subject to possible redemption |
Loading...
